Multiple sclerosis (MS) is the most common neurological disorder among young adults and often results in a handicap. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
... is an indispensable tool for diagnosing, monitoring and treating MS. However, it is not an infallible tool and a certain nuance must be shown. Prof. Dr. Christian Sindic explains this in our newsletter.
"... only in this way will you ever come to see." This was the motto of Prof Jean-Martin Charcot. In 1868, he was the first to define multiple sclerosis (MS).
Is the location of the lesions important or is it rather their number? Can the MRI result indicate when to change treatment? Dr. Solène Dauby gives the answers.
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
